Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vita Life SciencesASX:VLS +0.81%80 3-Year Dividend Growth Rate is 23.80% as of Dec. 2025, which is 42% above its 10-year median of 16.75. GuruFocus rates ASX:VLS with a GF Score™ of 80/100 and a GF Value™ of A$2.50 (Fairly Valued). The stock has 1 warning sign investors should review. Among 352 Drug Manufacturers companies, Vita Life Sciences ranks better than 73.3% on this metric.
The historical rank and industry rank for Vita Life Sciences's 3-Year Dividend Growth Rate or its related term are showing as below:
ASX:VLS'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0 Med: 16.75 Max: 91.3
Current: 23.8
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Vita Life Sciences was 91.30% per year. The lowest was 0.00% per year. And the median was 16.75% per year.
ASX:VLS's 3-Year Dividend Growth Rate is ranked better than 73.3% of 352
companies
in the Drug Manufacturers industry
Industry Median: 7.7
vs ASX:VLS: 23.80
During the past 12 months, Vita Life Sciences's average Dividends Per Share Growth Rate was 15.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 23.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 22.30% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 11.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Vita Life Sciences was 0.86. The lowest was 0.33. And the median was 0.60.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Vita Life Sciences Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 0.095000
2026-03-27
2026-03-30
2026-04-10
Cash Dividend
semi-annually
AUD:AUD 1.000000
AUD 0.045000
2025-09-19
2025-09-22
2025-10-03
Cash Dividend
semi-annually
AUD:AUD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Vita Life Sciences's Dividend Yield (%) for Today is calculated as
Current Share Price is A$2.50.
Vita Life Sciences's Dividends per Share for the trailing twelve months (TTM) ended in Today is A$0.14.
During the past 13 years, the highest Dividend Yield of Vita Life Sciences was 7.04%. The lowest was 1.97%. And the median was 3.89%.
Good Sign:
Vita Life Sciences Ltd stock Dividend Yield % is close to 5-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vita Life Sciences 3-Year Dividend Growth Rate Related Terms>
ASX:VLS vs ZTS: 3-Year Dividend Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vita Life Sciences's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vita Life Sciences 3-Year Dividend Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vita Life Sciences's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Vita Life Sciences's 3-Year Dividend Growth Rate falls into.
Vita Life Sciences 3-Year Dividend Growth Rate Calculation
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 23.80% mean?
Vita Life Sciences (ASX:VLS) has a 3-Year Dividend Growth Rate of 23.80% as of Dec. 2025. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Vita Life Sciences and its competitors. This is 42% above median its historical median of 16.75. According to the industry distribution chart, Vita Life Sciences ranks #94 out of 352 companies in the Drug Manufacturers industry, placing it in the top 26.7%.
Is Vita Life Sciences' 3-Year Dividend Growth Rate too high?
Vita Life Sciences' current 3-Year Dividend Growth Rate of 23.80% is 42% above median its 10-year median of 16.75. The Drug Manufacturers industry median 3-Year Dividend Growth Rate is 7.70. Vita Life Sciences' value of 23.80% is 209.1% above this industry median. Based on the distribution chart, Vita Life Sciences ranks #94 out of 352 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Vita Life Sciences has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vita Life Sciences' 3-Year Dividend Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vita Life Sciences ranks #94 out of 352 companies for 3-Year Dividend Growth Rate. This puts Vita Life Sciences in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 7.70. Vita Life Sciences' value of 23.80% is 209.1% above this benchmark. While the company's 10-year median is 16.75 vs. the industry median of 7.70, Vita Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Drug Manufacturers company?
The median 3-Year Dividend Growth Rate among Drug Manufacturers companies is 7.70, based on 352 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vita Life Sciences's current 3-Year Dividend Growth Rate of 23.80% is 209.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Vita Life Sciences and its competitors. For the Drug Manufacturers industry, the median 3-Year Dividend Growth Rate is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vita Life Sciences's current 3-Year Dividend Growth Rate is 23.80%, which is 42% above median its own 10-year median of 16.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vita Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Vita Life Sciences (ASX:VLS) is currently considered Fairly Valued. The stock's GF Value™ is A$2.50, compared to a current price of A$2.50 — trading right at its estimated fair value. The current 3-Year Dividend Growth Rate is 23.80%, which is 42% above median its 10-year median of 16.75 and 209.1% above the Drug Manufacturers industry median of 7.70. Vita Life Sciences' overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Vita Life Sciences (ASX:VLS), the current 3-Year Dividend Growth Rate is 23.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vita Life Sciences (ASX:VLS) Overvalued in 2026?
Based on GuruFocus' analysis, Vita Life Sciences stock appears to be undervalued.
The current stock price of A$2.50 is trading 0% below its estimated GF Value™ of A$2.50.
GuruFocus considers Vita Life Sciences to be Fairly Valued.
Key valuation signals for ASX:VLS:
3-Year Dividend Growth Rate: 23.80% (42% above median its 10-year median of 16.75)
GF Value™: A$2.50 vs. price of A$2.50 (0% below fair value)
Industry Position: 209.1% above the Drug Manufacturers median (#94 of 352)
No single metric tells the full story. See the ASX:VLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.
80GF Score
Get the complete analysis for ASX:VLS
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VLS has been successfully added to your 
